Idogen has been delisted from First North Growth Market
Idogen AB has July 7 202 been declared in bankruptcy by the tribunal of Lund. Nasdaq has decided to delist Idogen as a consequence of the bankruptcy. Further communication regarding the bankruptcy will be published in the official gazette ( Post och Inrikestidningar). For further information, please contact: Christina Herder, acting CEO, Idogen AB Tel: +46 70 374 71 56 E-mail: christina.herder@idogen.com The information was submitted for publication through the agency of the contact persons set out above on July 7, 2023, at 16:01 CET.